Study of BKM120 or BYL719 and Capecitabine in Patients With Metastatic Breast Cancer
Clinical trial NCT01300962 · COMPLETED
Trial details
- NCT number
- NCT01300962
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-01
- Primary completion
- 2017-02-07
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.